Review, Systematic [inpr]
economic evaluation [ocac]
Statins [orch, phsu]
Prevention [topp]
coronary [bpoc]
Events [evnt]
objectives [inpr]
Evaluate [ftcn]
Effectiveness [qlco]
Cost Effectiveness [qnco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
cardiovascular events [fndg]
Adults [aggp]
coronary heart disease [dsyn]
Data Sources [qnco]
Database, Electronic [inpr]
Searched [acty]
Methods [inpr]
Evaluate [ftcn]
Literature [inpr]
Relate [orch]
Cost Effectiveness [qnco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
coronary heart disease [dsyn]
Cardiovascular disease [dsyn]
Costs [qnco]
Health Outcomes [inpr]
Statin [orch, phsu]
treatment [ftcn]
NHS [cgab, dsyn]
Identified [qlco]
Compared [acty]
Statin [orch, phsu]
placebo [topp]
Statin [orch, phsu]
Reported [inpr]
Meta-Analysis [inpr]
Available [ftcn]
placebo controlled study [inpr, resa]
Patients [podg]
Cardiovascular disease [dsyn]
Statin [orch, phsu]
therapy [ftcn]
Reduced [qlco]
Relative Risk [qnco]
Mortality [qnco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
coronary heart disease [dsyn]
Mortality [qnco]
Fatal [qlco]
Myocardial Infarction [dsyn]
Fatal [qlco]
Stroke [dsyn]
Reduced [qlco]
Relative Risk [qnco]
Morbidity [qnco]
Fatal [qlco]
Stroke [dsyn]
Fatal [qlco]
Myocardial Infarction [dsyn]
Transient Ischemic Attack [dsyn]
Angina, Unstable [dsyn]
coronary revascularisation [topp]
Available [ftcn]
placebo-controlled [resa]
Trial [resa]
differentiate [qlco]
Efficacy [qlco]
atorvastatin [orch, phsu]
fluvastatin [orch, phsu]
Pravastatin [orch, phsu]
Simvastatin [orch, phsu]
Direct [qlco]
Comparison [acty]
Statins [orch, phsu]
Suggest [idcn]
atorvastatin [orch, phsu]
effective [qlco]
Pravastatin [orch, phsu]
Patients [podg]
Symptomatic [ftcn]
coronary heart disease [dsyn]
Limited [ftcn]
Effectiveness [qlco]
Statins [orch, phsu]
subgroups [virs]
Statins [orch, phsu]
considered [idcn]
Well [qlco]
Good [qlco]
Safety [hcpp]
Profile [lbpr]
View [spco]
Supported [cnce]
Trial [resa]
included [ftcn]
surveillance [ftcn]
increases [ftcn]
Creatine Kinase [aapp, enzy]
Myopathy [dsyn]
Reported [inpr]
Rhabdomyolysis [patf]
Hepatotoxicity [inpo]
Rare [tmco]
Patients [podg]
Receive [qlco]
Lipid-lowering therapy [topp]
Long [qlco]
Safety [hcpp]
Timespan [tmco]
Unknown [qlco]
Secondary Prevention [topp]
coronary heart disease [dsyn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Age [orga]
pound [qnco]
pound [qnco]
Year, Quality-Adjusted Life [tmco]
Age [orga]
Sensitivity [qnco]
Robust [qlco]
Primary Prevention [topp]
coronary heart disease [dsyn]
Variation [qlco]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Age [orga]
Average [qnco]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
weighted [orga]
Range [qnco]
pound [qnco]
pound [qnco]
Men [popg]
pound [qnco]
pound [qnco]
Women [popg]
Sensitive [ftcn]
Cost [qnco]
Statins [orch, phsu]
discount rates [qnco]
Modeling [inpr, resa]
Time frame [tmco]
Cardiovascular disease [dsyn]
Take [hlca]
account [idcn]
Benefits [qnco]
Statins [orch, phsu]
reductions [npop]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Events [evnt]
Average [qnco]
ICER [gngm]
weighted [orga]
pound [qnco]
Coronary heart disease risk [inpr]
limitations [ftcn]
Requirement [ftcn]
Well [qlco]
Time frame [tmco]
Trial [resa]
Effectiveness [qlco]
High Risk Populations [popg]
Primary Prevention [topp]
treatment [ftcn]
Low Risk [fndg]
Age [orga]
Bands [medd]
Risks [qlco]
Uncertainty [idcn]
Need [qlco]
treated [topp]
Conclusions [idcn]
Suggest [idcn]
Statin [orch, phsu]
therapy [ftcn]
statistically significant [qnco]
reduction [npop]
Primary [qlco]
secondary [neop]
cardiovascular events [fndg]
Confidence Intervals [qnco]
Prevention [topp]
Category [inpr]
overlap [topp]
differentiate [qlco]
Relative Risk [qnco]
Effectiveness [qlco]
Statins [orch, phsu]
Primary [qlco]
Secondary Prevention [topp]
absolute risk [qnco]
coronary heart disease [dsyn]
Fatal [qlco]
Myocardial Infarction [dsyn]
Needed [qlco]
Event [evnt]
secondary [neop]
Primary Prevention [topp]
Limited [ftcn]
EXCLUSION [ftcn]
Patients [podg]
intolerant [ftcn]
Known [qlco]
Unresponsive [ftcn]
Statins [orch, phsu]
Compliant [qlco]
Study [mnob]
Medication [phsu]
placebo [topp]
RUN-IN [tmco]
Phase [tmco]
Treatment Effect [fndg]
Reduced [qlco]
Statins [orch, phsu]
Economic [ocdi]
Modeling [inpr, resa]
Statin [orch, phsu]
therapy [ftcn]
Secondary Prevention [topp]
Likely [qlco]
considered [idcn]
Cost Effectiveness [qnco]
Primary Prevention [topp]
Cost Effectiveness [qnco]
Ratios [qnco]
Dependent [qlco]
Coronary heart disease risk [inpr]
Age [orga]
Cardiovascular disease [dsyn]
Support [medd]
aggressive [mobd]
treatment [ftcn]
Recommendation [idcn]
Issue [fndg]
Guidelines [inpr]
Clinical Endpoint [clna]
rosuvastatin [orch, phsu]
On [ftcn]
Trial [resa]
Targeting [ftcn]
Statins [orch, phsu]
Low Risk [fndg]
uncertainties [idcn]
Likely [qlco]
Uptake [phsf]
Compliance [qnco]
Medication [phsu]
Asymptomatic [fndg]
Young [tmco]
Patients [podg]
Targeting [ftcn]
Assessment [hlca]
Monitoring [hlca]
Low Risk [fndg]
Patients [podg]
Primary Care [hlca]
Resource [idcn]
NHS [cgab, dsyn]
